Mengqi Gao

机构：Nanjing University of Chinese Medicine, Second Affiliated Hospital of Guangzhou Medical University, Qilu Hospital of Shandong University, Guangzhou Medical University · ORCID：0000-0002-1428-891X

发表论文 42 篇 · 总被引 1370 次 · h-index 14

代表论文

• Diabetic vascular diseases: molecular mechanisms and therapeutic strategies (2023 · Signal Transduction and Targeted Therapy · 被引 673)
• Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence (2023 · Annals of Medicine · 被引 78)
• Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR (2023 · Journal of Ovarian Research · 被引 68)
• Mechanism and nanotechnological-based therapeutics for tolerance and resistance of bacterial biofilms (2024 · Microbiological Research · 被引 16)
• Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses (2024 · Biomedicine & Pharmacotherapy · 被引 16)
• The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis (2024 · Heliyon · 被引 14)